Categories
Zydus Lifesciences Limited — Updates, 30-04-2026: General Updates
30-04-2026 · 11:25 am
Zydus Lifesciences has formed Zara Merger SUB Inc., a 100% owned pharmaceutical subsidiary in the US, for internal group restructuring. The new entity has authorized capital of 1,000 shares at USD 0.001 each, fully subscribed in cash.
No comments yet. Be the first to comment!